Patents by Inventor Patrick W. Papa

Patrick W. Papa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CK1 alpha AND DUAL CK1 alpha / GSPT1 DEGRADING COMPOUNDS
    Publication number: 20240158370
    Abstract: Provided herein are compounds that act as molecular glues, inducing degradation of CK1? or CK1?/GSPT1, and pharmaceutically acceptable derivatives thereof. Also provided are pharmaceutical compositions containing the compounds and methods of using the compounds for treating a subject with a proliferative disease.
    Type: Application
    Filed: September 6, 2023
    Publication date: May 16, 2024
    Inventors: Patrick W. Papa, Veronique Plantevin-Krenitsky, Paul J. Krenitsky, Frank Mercurio, Derek Mendy, Michael P. Haughey, Weilin Xie, Jan Elsner, John Sapienza
  • Carboxylic Acid Containing Indanyl Compounds for the Treatment of Neurodegenerative Diseases
    Publication number: 20240124394
    Abstract: Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
    Type: Application
    Filed: December 22, 2021
    Publication date: April 18, 2024
    Applicant: Celgene Corporation
    Inventors: Jeffrey M. Schkeryantz, Julie Selkirk, Philip Stewart Turnbull, Junko Tamiya, Patrick W. Papa, Jean-Francois Brazeau, Karin Worm
  • Carboxylic acid containing azetidinyl compounds for the treatment of neurodegenerative diseases
    Patent number: 11919879
    Abstract: Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
    Type: Grant
    Filed: June 15, 2022
    Date of Patent: March 5, 2024
    Assignee: Celgene Corporation
    Inventors: Jeffrey M. Schkeryantz, Karin Worm, Rulin Ma, Patrick W. Papa
  • Carboxylic Acid Containing Azetidinyl Compounds for the Treatment of Neurodegenerative Diseases
    Publication number: 20230028747
    Abstract: Provided herein are compounds and compositions thereof for modulating S1P5. In some embodiments, the compounds and compositions are provided for treatment of neurological diseases.
    Type: Application
    Filed: June 15, 2022
    Publication date: January 26, 2023
    Applicant: Celgene Corporation
    Inventors: Jeffrey M. Schkeryantz, Karin Worm, Rulin Ma, Patrick W. Papa